Skip to main content
Erschienen in: PharmacoEconomics 11/2015

01.11.2015 | Systematic Review

Can The EQ-5D Detect Meaningful Change? A Systematic Review

verfasst von: Nalin Payakachat, Mir M. Ali, J. Mick Tilford

Erschienen in: PharmacoEconomics | Ausgabe 11/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

The EQ-5D is one of the most frequently used, generic, preference-based instruments for measuring the health utilities of patients in economic evaluations. It is recommended for health technology assessment by the National Institute for Health and Clinical Excellence. Because the EQ-5D plays such an important role in economic evaluations, useful information on its responsiveness to detect meaningful change in health status is required.

Objective

This study systematically reviewed and synthesized evidence on the responsiveness of the EQ-5D to detect meaningful change in health status for clinical research and economic evaluations.

Methods

We searched the EuroQol website, PubMed, PsychINFO, and EconLit databases to identify studies published in English from the inception of the EQ-5D until August 15, 2014 using keywords that were related to responsiveness. Studies that used only the EQ-VAS were excluded from the final analysis. Narrative synthesis was conducted to summarize evidence on the responsiveness of the EQ-5D by conditions or physiological functions.

Results

Of 1401 studies, 145 were included in the narrative synthesis and categorized into 19 categories for 56 conditions. The EQ-5D was found to be responsive in 25 conditions (45 %) with the magnitude of responsiveness varying from small to large depending on the condition. There was mixed evidence of responsiveness in 27 conditions (48 %). Only four conditions (7 %) (i.e., alcohol dependency, schizophrenia, limb reconstruction, and hearing impairment) were identified where the EQ-5D was not responsive.

Conclusion

The EQ-5D is an appropriate measure for economic evaluation and health technology assessment in conditions where it has demonstrated evidence of responsiveness. In conditions with mixed evidence of responsiveness, researchers should consider using the EQ-5D with other condition-specific measures to ensure appropriate estimates of effectiveness. These conditions should be a main focus for future research using the new EQ-5D version with five response levels.
Literatur
1.
3.
Zurück zum Zitat Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA. 1996;276(15):1253–8.PubMedCrossRef Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA. 1996;276(15):1253–8.PubMedCrossRef
4.
Zurück zum Zitat Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001;33(5):337–43.PubMedCrossRef Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001;33(5):337–43.PubMedCrossRef
5.
Zurück zum Zitat Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21(2):271–92.PubMedCrossRef Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21(2):271–92.PubMedCrossRef
6.
Zurück zum Zitat Brazier JE, Roberts J. The estimation of a preference-based measure of health from the SF-12. Med Care. 2004;42(9):851–9.PubMedCrossRef Brazier JE, Roberts J. The estimation of a preference-based measure of health from the SF-12. Med Care. 2004;42(9):851–9.PubMedCrossRef
7.
Zurück zum Zitat Feeny D, Furlong W, Torrance GW, Goldsmith CH, Zhu Z, DePauw S, Denton M, Boyle M. Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. Med Care. 2002;40(2):113–28.PubMedCrossRef Feeny D, Furlong W, Torrance GW, Goldsmith CH, Zhu Z, DePauw S, Denton M, Boyle M. Multiattribute and single-attribute utility functions for the health utilities index mark 3 system. Med Care. 2002;40(2):113–28.PubMedCrossRef
9.
Zurück zum Zitat Gray AM, Clarke P, Wolstenholme J, Wordsworth S. Measuring, valuing, and analysing health outcomes. In: Gray AM, Clarke P, Wolstenholme J, Wordsworth S, editors. Applied methods of cost-effectiveness analysis in healthcare. New York: Oxford University Press; 2011. p. 83–118. Gray AM, Clarke P, Wolstenholme J, Wordsworth S. Measuring, valuing, and analysing health outcomes. In: Gray AM, Clarke P, Wolstenholme J, Wordsworth S, editors. Applied methods of cost-effectiveness analysis in healthcare. New York: Oxford University Press; 2011. p. 83–118.
10.
Zurück zum Zitat Szende A, Oppe M, Devlin N. EQ-5D value sets: Inventory, comparative review and user guide. EuroQol Group Monographs, vol 2. Dordrecht, The Netherlands: Springer; 2007. Szende A, Oppe M, Devlin N. EQ-5D value sets: Inventory, comparative review and user guide. EuroQol Group Monographs, vol 2. Dordrecht, The Netherlands: Springer; 2007.
11.
Zurück zum Zitat Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, Bonsel G, Badia X. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727–36.PubMedCentralPubMedCrossRef Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, Bonsel G, Badia X. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727–36.PubMedCentralPubMedCrossRef
13.
Zurück zum Zitat Brazier J, Connell J, Papaioannou D, Mukuria C, Mulhern B, Peasgood T, Jones ML, Paisley S, O’Cathain A, Barkham M, Knapp M, Byford S, Gilbody S, Parry G. A systematic review, psychometric analysis and qualitative assessment of generic preference-based measures of health in mental health populations and the estimation of mapping functions from widely used specific measures. Health Technol Assess. 2014;18(34):11–19 (vii-viii, xiii-xxv, 1–188).CrossRef Brazier J, Connell J, Papaioannou D, Mukuria C, Mulhern B, Peasgood T, Jones ML, Paisley S, O’Cathain A, Barkham M, Knapp M, Byford S, Gilbody S, Parry G. A systematic review, psychometric analysis and qualitative assessment of generic preference-based measures of health in mental health populations and the estimation of mapping functions from widely used specific measures. Health Technol Assess. 2014;18(34):11–19 (vii-viii, xiii-xxv, 1188).CrossRef
14.
Zurück zum Zitat Yang Y, Brazier J, Longworth L. EQ-5D in skin conditions: an assessment of validity and responsiveness. Eur J Health Econ. 2014. [Epub ahead of print]. Yang Y, Brazier J, Longworth L. EQ-5D in skin conditions: an assessment of validity and responsiveness. Eur J Health Econ. 2014. [Epub ahead of print].
16.
Zurück zum Zitat Pickard AS, Wilke C, Jung E, Patel S, Stavem K, Lee TA. Use of a preference-based measure of health (EQ-5D) in COPD and asthma. Respir Med. 2008;102(4):519–36.PubMedCrossRef Pickard AS, Wilke C, Jung E, Patel S, Stavem K, Lee TA. Use of a preference-based measure of health (EQ-5D) in COPD and asthma. Respir Med. 2008;102(4):519–36.PubMedCrossRef
17.
Zurück zum Zitat Tordrup D, Mossman J, Kanavos P. Responsiveness of the EQ-5D to clinical change: is the patient experience adequately represented? Int J Technol Assess Health Care. 2014;30(1):10–9.PubMedCrossRef Tordrup D, Mossman J, Kanavos P. Responsiveness of the EQ-5D to clinical change: is the patient experience adequately represented? Int J Technol Assess Health Care. 2014;30(1):10–9.PubMedCrossRef
19.
Zurück zum Zitat Walters SJ. Quality of life outcomes in clinical trials and health-care evaluation: a practical guide to analysis and interpretation. Chichester: Wiley; 2009.CrossRef Walters SJ. Quality of life outcomes in clinical trials and health-care evaluation: a practical guide to analysis and interpretation. Chichester: Wiley; 2009.CrossRef
20.
Zurück zum Zitat Hays RD, Revicki DA. Reliability and validity (including responsiveness). In: Fayers PM, Hays RD, editors. Assessing quality of life in clinical trials. 2nd ed. New York: Oxford University Press; 2005. p. 25–39. Hays RD, Revicki DA. Reliability and validity (including responsiveness). In: Fayers PM, Hays RD, editors. Assessing quality of life in clinical trials. 2nd ed. New York: Oxford University Press; 2005. p. 25–39.
23.
Zurück zum Zitat Günther OH, Roick C, Angermeyer MC, König HH. Responsiveness of EQ-5D utility indices in alcohol-dependent patients. Drug Alcohol Depend. 2008;92(1–3):291–5.PubMedCrossRef Günther OH, Roick C, Angermeyer MC, König HH. Responsiveness of EQ-5D utility indices in alcohol-dependent patients. Drug Alcohol Depend. 2008;92(1–3):291–5.PubMedCrossRef
24.
Zurück zum Zitat Essex HN, White IR, Khadjesari Z, Linke S, McCambridge J, Murray E, Parrott S, Godfrey C. Quality of life among hazardous and harmful drinkers: EQ-5D over a 1-year follow-up period. Qual Life Res. 2014;23(2):733–43.PubMedCrossRef Essex HN, White IR, Khadjesari Z, Linke S, McCambridge J, Murray E, Parrott S, Godfrey C. Quality of life among hazardous and harmful drinkers: EQ-5D over a 1-year follow-up period. Qual Life Res. 2014;23(2):733–43.PubMedCrossRef
25.
Zurück zum Zitat Papaioannou D, Brazier J, Parry G. How valid and responsive are generic health status measures, such as EQ-5D and SF-36, in schizophrenia? A systematic review. Value Health. 2011;14(6):907–20.PubMedCentralPubMedCrossRef Papaioannou D, Brazier J, Parry G. How valid and responsive are generic health status measures, such as EQ-5D and SF-36, in schizophrenia? A systematic review. Value Health. 2011;14(6):907–20.PubMedCentralPubMedCrossRef
26.
Zurück zum Zitat Burton M, Walters SJ, Saleh M, Brazier JE. An evaluation of patient-reported outcome measures in lower limb reconstruction surgery. Qual Life Res. 2012;21(10):1731–43.PubMedCrossRef Burton M, Walters SJ, Saleh M, Brazier JE. An evaluation of patient-reported outcome measures in lower limb reconstruction surgery. Qual Life Res. 2012;21(10):1731–43.PubMedCrossRef
27.
Zurück zum Zitat Yang Y, Longworth L, Brazier J. An assessment of validity and responsiveness of generic measures of health-related quality of life in hearing impairment. Qual Life Res. 2013;22(10):2813–28.PubMedCentralPubMedCrossRef Yang Y, Longworth L, Brazier J. An assessment of validity and responsiveness of generic measures of health-related quality of life in hearing impairment. Qual Life Res. 2013;22(10):2813–28.PubMedCentralPubMedCrossRef
28.
Zurück zum Zitat Bouwmans C, van der Kolk A, Oppe M, Schawo S, Stolk E, van Agthoven M, Buitelaar J, van Roijen L. Validity and responsiveness of the EQ-5D and the KIDSCREEN-10 in children with ADHD. Eur J Health Econ. 2014;15(9):967–77.PubMedCrossRef Bouwmans C, van der Kolk A, Oppe M, Schawo S, Stolk E, van Agthoven M, Buitelaar J, van Roijen L. Validity and responsiveness of the EQ-5D and the KIDSCREEN-10 in children with ADHD. Eur J Health Econ. 2014;15(9):967–77.PubMedCrossRef
29.
Zurück zum Zitat Kiessling A, Henriksson P. Time trends of chest pain symptoms and health related quality of life in coronary artery disease. Health Qual Life Outcomes. 2007;5:13.PubMedCentralPubMedCrossRef Kiessling A, Henriksson P. Time trends of chest pain symptoms and health related quality of life in coronary artery disease. Health Qual Life Outcomes. 2007;5:13.PubMedCentralPubMedCrossRef
31.
Zurück zum Zitat Eurich DT, Johnson JA, Reid KJ, Spertus JA. Assessing responsiveness of generic and specific health related quality of life measures in heart failure. Health Qual Life Outcomes. 2006;4:89.PubMedCentralPubMedCrossRef Eurich DT, Johnson JA, Reid KJ, Spertus JA. Assessing responsiveness of generic and specific health related quality of life measures in heart failure. Health Qual Life Outcomes. 2006;4:89.PubMedCentralPubMedCrossRef
32.
Zurück zum Zitat Kaplan RM, Tally S, Hays RD, Feeny D, Ganiats TG, Palta M, Fryback DG. Five preference-based indexes in cataract and heart failure patients were not equally responsive to change. J Clin Epidemiol. 2011;64(5):497–506.PubMedCentralPubMedCrossRef Kaplan RM, Tally S, Hays RD, Feeny D, Ganiats TG, Palta M, Fryback DG. Five preference-based indexes in cataract and heart failure patients were not equally responsive to change. J Clin Epidemiol. 2011;64(5):497–506.PubMedCentralPubMedCrossRef
33.
Zurück zum Zitat Pickard AS, Johnson JA, Feeny DH. Responsiveness of generic health-related quality of life measures in stroke. Qual Life Res. 2005;14(1):207–19.PubMedCrossRef Pickard AS, Johnson JA, Feeny DH. Responsiveness of generic health-related quality of life measures in stroke. Qual Life Res. 2005;14(1):207–19.PubMedCrossRef
34.
Zurück zum Zitat Hunger M, Sabariego C, Stollenwerk B, Cieza A, Leidl R. Validity, reliability and responsiveness of the EQ-5D in German stroke patients undergoing rehabilitation. Qual Life Res. 2012;21(7):1205–16.PubMedCrossRef Hunger M, Sabariego C, Stollenwerk B, Cieza A, Leidl R. Validity, reliability and responsiveness of the EQ-5D in German stroke patients undergoing rehabilitation. Qual Life Res. 2012;21(7):1205–16.PubMedCrossRef
35.
Zurück zum Zitat Nosyk B, Sun H, Guh DP, Oviedo-Joekes E, Marsh DC, Brissette S, Schechter MT, Anis AH. The quality of eight health status measures were compared for chronic opioid dependence. J Clin Epidemiol. 2010;63(10):1132–44.PubMedCrossRef Nosyk B, Sun H, Guh DP, Oviedo-Joekes E, Marsh DC, Brissette S, Schechter MT, Anis AH. The quality of eight health status measures were compared for chronic opioid dependence. J Clin Epidemiol. 2010;63(10):1132–44.PubMedCrossRef
36.
Zurück zum Zitat Mulhern B, Mukuria C, Barkham M, Knapp M, Byford S, Soeteman D, Brazier J. Using generic preference-based measures in mental health: psychometric validity of the EQ-5D and SF-6D. Br J Psychiatry. 2014;205(3):236–43.PubMedCrossRef Mulhern B, Mukuria C, Barkham M, Knapp M, Byford S, Soeteman D, Brazier J. Using generic preference-based measures in mental health: psychometric validity of the EQ-5D and SF-6D. Br J Psychiatry. 2014;205(3):236–43.PubMedCrossRef
38.
Zurück zum Zitat Sonntag M, Konnopka A, Leichsenring F, Salzer S, Beutel ME, Herpertz S, Hiller W, Hoyer J, Joraschky P, Nolting B, Pöhlmann K, Stangier U, Strauss B, Willutzki U, Wiltink J, Leibing E, König HH. Reliability, validity and responsiveness of the EQ-5D in assessing and valuing health status in patients with social phobia. Health Qual Life Outcomes. 2013;11:215. doi:10.1186/1477-7525-11-215.:215-11.PubMedCentralPubMedCrossRef Sonntag M, Konnopka A, Leichsenring F, Salzer S, Beutel ME, Herpertz S, Hiller W, Hoyer J, Joraschky P, Nolting B, Pöhlmann K, Stangier U, Strauss B, Willutzki U, Wiltink J, Leibing E, König HH. Reliability, validity and responsiveness of the EQ-5D in assessing and valuing health status in patients with social phobia. Health Qual Life Outcomes. 2013;11:215. doi:10.​1186/​1477-7525-11-215.​:​215-11.PubMedCentralPubMedCrossRef
39.
Zurück zum Zitat Brettschneider C, König HH, Herzog W, Kaufmann C, Schaefert R, Konnopka A. Validity and responsiveness of the EQ-5D in assessing and valuing health status in patients with somatoform disorders. Health Qual Life Outcomes. 2013;11:3.PubMedCentralPubMedCrossRef Brettschneider C, König HH, Herzog W, Kaufmann C, Schaefert R, Konnopka A. Validity and responsiveness of the EQ-5D in assessing and valuing health status in patients with somatoform disorders. Health Qual Life Outcomes. 2013;11:3.PubMedCentralPubMedCrossRef
40.
Zurück zum Zitat Harrison MJ, Davies LM, Bansback NJ, McCoy MJ, Verstappen SM, Watson K. Symmons DP; British Society for Rheumatology Biologics Register Control Centre Consortium. The comparative responsiveness of the EQ-5D and SF-6D to change in patients with inflammatory arthritis. Qual Life Res. 2009;18(9):1195–205.PubMedCentralPubMedCrossRef Harrison MJ, Davies LM, Bansback NJ, McCoy MJ, Verstappen SM, Watson K. Symmons DP; British Society for Rheumatology Biologics Register Control Centre Consortium. The comparative responsiveness of the EQ-5D and SF-6D to change in patients with inflammatory arthritis. Qual Life Res. 2009;18(9):1195–205.PubMedCentralPubMedCrossRef
41.
Zurück zum Zitat Hagel S, Lindqvist E, Petersson IF, Nilsson JÅ, Bremander A. Validation of outcome measurement instruments used in a multidisciplinary rehabilitation intervention for patients with chronic inflammatory arthritis: linking of the International Classification of Functioning, Disability and Health, construct validity and responsiveness to change. J Rehabil Med. 2011;43(5):411–9.PubMedCrossRef Hagel S, Lindqvist E, Petersson IF, Nilsson JÅ, Bremander A. Validation of outcome measurement instruments used in a multidisciplinary rehabilitation intervention for patients with chronic inflammatory arthritis: linking of the International Classification of Functioning, Disability and Health, construct validity and responsiveness to change. J Rehabil Med. 2011;43(5):411–9.PubMedCrossRef
42.
Zurück zum Zitat Gaujoux-Viala C, Rat AC, Guillemin F, Flipo RM, Fardellone P, Bourgeois P, Fautrel B. Responsiveness of EQ-5D and SF-6D in patients with early arthritis: results from the ESPOIR cohort. Ann Rheum Dis. 2012;71(9):1478–83.PubMedCrossRef Gaujoux-Viala C, Rat AC, Guillemin F, Flipo RM, Fardellone P, Bourgeois P, Fautrel B. Responsiveness of EQ-5D and SF-6D in patients with early arthritis: results from the ESPOIR cohort. Ann Rheum Dis. 2012;71(9):1478–83.PubMedCrossRef
43.
Zurück zum Zitat Hurst NP, Kind P, Ruta D, Hunter M, Stubbings A. Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). Br J Rheumatol. 1997;36(5):551–9.PubMedCrossRef Hurst NP, Kind P, Ruta D, Hunter M, Stubbings A. Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). Br J Rheumatol. 1997;36(5):551–9.PubMedCrossRef
44.
Zurück zum Zitat Eversden L, Maggs F, Nightingale P, Jobanputra P. A pragmatic randomized controlled trial of hydrotherapy and land exercises on overall well being and quality of life in rheumatoid arthritis. BMC Musculoskelet Disord. 2007;8:23.PubMedCentralPubMedCrossRef Eversden L, Maggs F, Nightingale P, Jobanputra P. A pragmatic randomized controlled trial of hydrotherapy and land exercises on overall well being and quality of life in rheumatoid arthritis. BMC Musculoskelet Disord. 2007;8:23.PubMedCentralPubMedCrossRef
45.
Zurück zum Zitat Linde L, Sørensen J, Ostergaard M, Hørslev-Petersen K, Hetland ML. Health-related quality of life: validity, reliability, and responsiveness of SF-36, 15D, EQ-5D [corrected] RAQoL, and HAQ in patients with rheumatoid arthritis. J Rheumatol. 2008;35(8):1528–37.PubMed Linde L, Sørensen J, Ostergaard M, Hørslev-Petersen K, Hetland ML. Health-related quality of life: validity, reliability, and responsiveness of SF-36, 15D, EQ-5D [corrected] RAQoL, and HAQ in patients with rheumatoid arthritis. J Rheumatol. 2008;35(8):1528–37.PubMed
46.
Zurück zum Zitat Buitinga L, Braakman-Jansen LM, Taal E, Kievit W, Visser H, van Riel PL, van de Laar MA. Comparative responsiveness of the EuroQol-5D and Short Form 6D to improvement in patients with rheumatoid arthritis treated with tumor necrosis factor blockers: results of the Dutch Rheumatoid Arthritis Monitoring registry. Arthritis Care Res (Hoboken). 2012;64(6):826–32.CrossRef Buitinga L, Braakman-Jansen LM, Taal E, Kievit W, Visser H, van Riel PL, van de Laar MA. Comparative responsiveness of the EuroQol-5D and Short Form 6D to improvement in patients with rheumatoid arthritis treated with tumor necrosis factor blockers: results of the Dutch Rheumatoid Arthritis Monitoring registry. Arthritis Care Res (Hoboken). 2012;64(6):826–32.CrossRef
47.
Zurück zum Zitat Haywood KL, Garratt AM, Dziedzic K, Dawes PT. Generic measures of health-related quality of life in ankylosing spondylitis: reliability, validity and responsiveness. Rheumatology (Oxford). 2002;41(12):1380–7.CrossRef Haywood KL, Garratt AM, Dziedzic K, Dawes PT. Generic measures of health-related quality of life in ankylosing spondylitis: reliability, validity and responsiveness. Rheumatology (Oxford). 2002;41(12):1380–7.CrossRef
48.
Zurück zum Zitat Conner-Spady B, Suarez-Almazor ME. Variation in the estimation of quality-adjusted life-years by different preference-based instruments. Med Care. 2003;41(7):791–801.PubMedCrossRef Conner-Spady B, Suarez-Almazor ME. Variation in the estimation of quality-adjusted life-years by different preference-based instruments. Med Care. 2003;41(7):791–801.PubMedCrossRef
49.
Zurück zum Zitat Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T, Mishima M. A comparison of the responsiveness of different generic health status measures in patients with asthma. Qual Life Res. 2003;12(5):555–63.PubMedCrossRef Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T, Mishima M. A comparison of the responsiveness of different generic health status measures in patients with asthma. Qual Life Res. 2003;12(5):555–63.PubMedCrossRef
50.
Zurück zum Zitat Petrillo J, van Nooten F, Jones P, Rutten-van Mölken M. Utility estimation in chronic obstructive pulmonary disease: a preference for change? Pharmacoeconomics. 2011;29(11):917–32.PubMedCrossRef Petrillo J, van Nooten F, Jones P, Rutten-van Mölken M. Utility estimation in chronic obstructive pulmonary disease: a preference for change? Pharmacoeconomics. 2011;29(11):917–32.PubMedCrossRef
51.
Zurück zum Zitat Paterson C, Langan CE, McKaig GA, Anderson PM, Maclaine GD, Rose LB, Walker SJ, Campbell MJ. Assessing patient outcomes in acute exacerbations of chronic bronchitis: the measure your medical outcome profile (MYMOP), medical outcomes study 6-item general health survey (MOS-6A) and EuroQol (EQ-5D). Qual Life Res. 2000;9(5):521–7.PubMedCrossRef Paterson C, Langan CE, McKaig GA, Anderson PM, Maclaine GD, Rose LB, Walker SJ, Campbell MJ. Assessing patient outcomes in acute exacerbations of chronic bronchitis: the measure your medical outcome profile (MYMOP), medical outcomes study 6-item general health survey (MOS-6A) and EuroQol (EQ-5D). Qual Life Res. 2000;9(5):521–7.PubMedCrossRef
52.
Zurück zum Zitat Jenkinson C, Gray A, Doll H, Lawrence K, Keoghane S, Layte R. Evaluation of index and profile measures of health status in a randomized controlled trial. Comparison of the Medical Outcomes Study 36-Item Short Form Health Survey, EuroQol, and disease specific measures. Med Care. 1997;35(11):1109–18.PubMedCrossRef Jenkinson C, Gray A, Doll H, Lawrence K, Keoghane S, Layte R. Evaluation of index and profile measures of health status in a randomized controlled trial. Comparison of the Medical Outcomes Study 36-Item Short Form Health Survey, EuroQol, and disease specific measures. Med Care. 1997;35(11):1109–18.PubMedCrossRef
53.
Zurück zum Zitat MacDonagh RP, Cliff AM, Speakman MJ, O’Boyle PJ, Ewings P, Gudex C. The use of generic measures of health-related quality of life in the assessment of outcome from transurethral resection of the prostate. Br J Urol. 1997;79(3):401–8.PubMedCrossRef MacDonagh RP, Cliff AM, Speakman MJ, O’Boyle PJ, Ewings P, Gudex C. The use of generic measures of health-related quality of life in the assessment of outcome from transurethral resection of the prostate. Br J Urol. 1997;79(3):401–8.PubMedCrossRef
54.
Zurück zum Zitat Krahn M, Bremner KE, Tomlinson G, Ritvo P, Irvine J, Naglie G. Responsiveness of disease-specific and generic utility instruments in prostate cancer patients. Qual Life Res. 2007;16(3):509–22.PubMedCrossRef Krahn M, Bremner KE, Tomlinson G, Ritvo P, Irvine J, Naglie G. Responsiveness of disease-specific and generic utility instruments in prostate cancer patients. Qual Life Res. 2007;16(3):509–22.PubMedCrossRef
56.
Zurück zum Zitat Lee CF, Luo N, Ng R, Wong NS, Yap YS, Lo SK, Chia WK, Yee A, Krishna L, Wong C, Goh C, Cheung YB. Comparison of the measurement properties between a short and generic instrument, the 5-level EuroQoL Group’s 5-dimension (EQ-5D-5L) questionnaire, and a longer and disease-specific instrument, the Functional Assessment of Cancer Therapy-Breast (FACT-B), in Asian breast cancer patients. Qual Life Res. 2013;22(7):1745–51.PubMedCrossRef Lee CF, Luo N, Ng R, Wong NS, Yap YS, Lo SK, Chia WK, Yee A, Krishna L, Wong C, Goh C, Cheung YB. Comparison of the measurement properties between a short and generic instrument, the 5-level EuroQoL Group’s 5-dimension (EQ-5D-5L) questionnaire, and a longer and disease-specific instrument, the Functional Assessment of Cancer Therapy-Breast (FACT-B), in Asian breast cancer patients. Qual Life Res. 2013;22(7):1745–51.PubMedCrossRef
57.
Zurück zum Zitat Krabbe PF, Peerenboom L, Langenhoff BS, Ruers TJ. Responsiveness of the generic EQ-5D summary measure compared to the disease-specific EORTC QLQ C-30. Qual Life Res. 2004;13(7):1247–53.PubMedCrossRef Krabbe PF, Peerenboom L, Langenhoff BS, Ruers TJ. Responsiveness of the generic EQ-5D summary measure compared to the disease-specific EORTC QLQ C-30. Qual Life Res. 2004;13(7):1247–53.PubMedCrossRef
58.
Zurück zum Zitat Kvam AK, Fayers PM, Wisloff F. Responsiveness and minimal important score differences in quality-of-life questionnaires: a comparison of the EORTC QLQ-C30 cancer-specific questionnaire to the generic utility questionnaires EQ-5D and 15D in patients with multiple myeloma. Eur J Haematol. 2011;87(4):330–7.PubMedCrossRef Kvam AK, Fayers PM, Wisloff F. Responsiveness and minimal important score differences in quality-of-life questionnaires: a comparison of the EORTC QLQ-C30 cancer-specific questionnaire to the generic utility questionnaires EQ-5D and 15D in patients with multiple myeloma. Eur J Haematol. 2011;87(4):330–7.PubMedCrossRef
59.
Zurück zum Zitat Davis S, Wailoo A. A review of the psychometric performance of the EQ-5D in people with urinary incontinence. Health Qual Life Outcomes. 2013;11:20.PubMedCentralPubMedCrossRef Davis S, Wailoo A. A review of the psychometric performance of the EQ-5D in people with urinary incontinence. Health Qual Life Outcomes. 2013;11:20.PubMedCentralPubMedCrossRef
60.
Zurück zum Zitat Kunz S. Psychometric properties of the EQ-5D in a study of people with mild to moderate dementia. Qual Life Res. 2010;19(3):425–34.PubMedCrossRef Kunz S. Psychometric properties of the EQ-5D in a study of people with mild to moderate dementia. Qual Life Res. 2010;19(3):425–34.PubMedCrossRef
61.
Zurück zum Zitat PD Med Collaborative Group. Gray R, Ives N, Rick C, Patel S, Gray A, Jenkinson C, McIntosh E, Wheatley K, Williams A, Clarke CE. Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson’s disease (PD MED): a large, open-label, pragmatic randomised trial. Lancet. 2014;384(9949):1196–205.CrossRef PD Med Collaborative Group. Gray R, Ives N, Rick C, Patel S, Gray A, Jenkinson C, McIntosh E, Wheatley K, Williams A, Clarke CE. Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson’s disease (PD MED): a large, open-label, pragmatic randomised trial. Lancet. 2014;384(9949):1196–205.CrossRef
62.
Zurück zum Zitat Luo N, Ng WY, Lau PN, Au WL, Tan LC. Responsiveness of the EQ-5D and 8-item Parkinson’s Disease Questionnaire (PDQ-8) in a 4-year follow-up study. Qual Life Res. 2010;19(4):565–9.PubMedCrossRef Luo N, Ng WY, Lau PN, Au WL, Tan LC. Responsiveness of the EQ-5D and 8-item Parkinson’s Disease Questionnaire (PDQ-8) in a 4-year follow-up study. Qual Life Res. 2010;19(4):565–9.PubMedCrossRef
63.
Zurück zum Zitat Schrag A, Spottke A, Quinn NP, Dodel R. Comparative responsiveness of Parkinson’s disease scales to change over time. Mov Disord. 2009;24(6):813–8.PubMedCrossRef Schrag A, Spottke A, Quinn NP, Dodel R. Comparative responsiveness of Parkinson’s disease scales to change over time. Mov Disord. 2009;24(6):813–8.PubMedCrossRef
64.
Zurück zum Zitat Langfitt JT, Vickrey BG, McDermott MP, Messing S, Berg AT, Spencer SS, Sperling MR, Bazil CW, Shinnar S. Validity and responsiveness of generic preference-based HRQOL instruments in chronic epilepsy. Qual Life Res. 2006;15(5):899–914.PubMedCrossRef Langfitt JT, Vickrey BG, McDermott MP, Messing S, Berg AT, Spencer SS, Sperling MR, Bazil CW, Shinnar S. Validity and responsiveness of generic preference-based HRQOL instruments in chronic epilepsy. Qual Life Res. 2006;15(5):899–914.PubMedCrossRef
65.
Zurück zum Zitat Janssen MF, Lubetkin EI, Sekhobo JP, Pickard AS. The use of the EQ-5D preference-based health status measure in adults with Type 2 diabetes mellitus. Diabet Med. 2011;28(4):395–413.PubMedCrossRef Janssen MF, Lubetkin EI, Sekhobo JP, Pickard AS. The use of the EQ-5D preference-based health status measure in adults with Type 2 diabetes mellitus. Diabet Med. 2011;28(4):395–413.PubMedCrossRef
66.
Zurück zum Zitat Riazi A, Cano SJ, Cooper JM, Bradley JL, Schapira AH, Hobart JC. Coordinating outcomes measurement in ataxia research: do some widely used generic rating scales tick the boxes? Mov Disord. 2006;21(9):1396–403.PubMedCrossRef Riazi A, Cano SJ, Cooper JM, Bradley JL, Schapira AH, Hobart JC. Coordinating outcomes measurement in ataxia research: do some widely used generic rating scales tick the boxes? Mov Disord. 2006;21(9):1396–403.PubMedCrossRef
67.
Zurück zum Zitat Godil SS, Parker SL, Zuckerman SL, Mendenhall SK, McGirt MJ. Accurately measuring outcomes after surgery for adult Chiari I malformation: determining the most valid and responsive instruments. Neurosurgery. 2013;72(5):820–7 discussion 827.PubMedCrossRef Godil SS, Parker SL, Zuckerman SL, Mendenhall SK, McGirt MJ. Accurately measuring outcomes after surgery for adult Chiari I malformation: determining the most valid and responsive instruments. Neurosurgery. 2013;72(5):820–7 discussion 827.PubMedCrossRef
68.
Zurück zum Zitat Sagberg LM, Jakola AS, Solheim O. Quality of life assessed with EQ-5D in patients undergoing glioma surgery: what is the responsiveness and minimal clinically important difference? Qual Life Res. 2014;23(5):1427–34.PubMedCrossRef Sagberg LM, Jakola AS, Solheim O. Quality of life assessed with EQ-5D in patients undergoing glioma surgery: what is the responsiveness and minimal clinically important difference? Qual Life Res. 2014;23(5):1427–34.PubMedCrossRef
70.
Zurück zum Zitat Tidermark J, Bergström G, Svensson O, Törnkvist H, Ponzer S. Responsiveness of the EuroQol (EQ 5-D) and the SF-36 in elderly patients with displaced femoral neck fractures. Qual Life Res. 2003;12(8):1069–79.PubMedCrossRef Tidermark J, Bergström G, Svensson O, Törnkvist H, Ponzer S. Responsiveness of the EuroQol (EQ 5-D) and the SF-36 in elderly patients with displaced femoral neck fractures. Qual Life Res. 2003;12(8):1069–79.PubMedCrossRef
71.
Zurück zum Zitat Tidermark J, Bergström G. Responsiveness of the EuroQol (EQ-5D) and the Nottingham Health Profile (NHP) in elderly patients with femoral neck fractures. Qual Life Res. 2007;16(2):321–30.PubMedCrossRef Tidermark J, Bergström G. Responsiveness of the EuroQol (EQ-5D) and the Nottingham Health Profile (NHP) in elderly patients with femoral neck fractures. Qual Life Res. 2007;16(2):321–30.PubMedCrossRef
72.
Zurück zum Zitat Frihagen F, Grotle M, Madsen JE, Wyller TB, Mowinckel P, Nordsletten L. Outcome after femoral neck fractures: a comparison of Harris Hip Score, Eq-5d and Barthel Index. Injury. 2008;39(10):1147–56.PubMedCrossRef Frihagen F, Grotle M, Madsen JE, Wyller TB, Mowinckel P, Nordsletten L. Outcome after femoral neck fractures: a comparison of Harris Hip Score, Eq-5d and Barthel Index. Injury. 2008;39(10):1147–56.PubMedCrossRef
73.
Zurück zum Zitat Godil SS, Parker SL, Zuckerman SL, Mendenhall SK, McGirt MJ. Accurately measuring the quality and effectiveness of cervical spine surgery in registry efforts: determining the most valid and responsive instruments. Spine J. 2013;. doi:10.1016/j.spinee.2013.07.444. Godil SS, Parker SL, Zuckerman SL, Mendenhall SK, McGirt MJ. Accurately measuring the quality and effectiveness of cervical spine surgery in registry efforts: determining the most valid and responsive instruments. Spine J. 2013;. doi:10.​1016/​j.​spinee.​2013.​07.​444.
74.
Zurück zum Zitat Olerud P, Tidermark J, Ponzer S, Ahrengart L, Bergström G. Responsiveness of the EQ-5D in patients with proximal humeral fractures. J Shoulder Elbow Surg. 2011;20(8):1200–6.PubMedCrossRef Olerud P, Tidermark J, Ponzer S, Ahrengart L, Bergström G. Responsiveness of the EQ-5D in patients with proximal humeral fractures. J Shoulder Elbow Surg. 2011;20(8):1200–6.PubMedCrossRef
75.
76.
Zurück zum Zitat Zampelis V, Ornstein E, Franzén H, Atroshi I. A simple visual analog scale for pain is as responsive as the WOMAC, the SF-36, and the EQ-5D in measuring outcomes of revision hip arthroplasty. Acta Orthop. 2014;85(2):128–32.PubMedCentralPubMedCrossRef Zampelis V, Ornstein E, Franzén H, Atroshi I. A simple visual analog scale for pain is as responsive as the WOMAC, the SF-36, and the EQ-5D in measuring outcomes of revision hip arthroplasty. Acta Orthop. 2014;85(2):128–32.PubMedCentralPubMedCrossRef
77.
Zurück zum Zitat Ostendorf M, van Stel HF, Buskens E, Schrijvers AJ, Marting LN, Verbout AJ, Dhert WJ. Patient-reported outcome in total hip replacement. A comparison of five instruments of health status. J Bone Joint Surg Br. 2004;86(6):801–8.PubMedCrossRef Ostendorf M, van Stel HF, Buskens E, Schrijvers AJ, Marting LN, Verbout AJ, Dhert WJ. Patient-reported outcome in total hip replacement. A comparison of five instruments of health status. J Bone Joint Surg Br. 2004;86(6):801–8.PubMedCrossRef
78.
Zurück zum Zitat Goodwin PC, Ratcliffe J, Morris J, Morrissey MC. Using the knee-specific Hughston Clinic Questionnaire, EQ-5D and SF-6D following arthroscopic partial meniscectomy surgery: a comparison of psychometric properties. Qual Life Res. 2011;20(9):1437–46.PubMedCrossRef Goodwin PC, Ratcliffe J, Morris J, Morrissey MC. Using the knee-specific Hughston Clinic Questionnaire, EQ-5D and SF-6D following arthroscopic partial meniscectomy surgery: a comparison of psychometric properties. Qual Life Res. 2011;20(9):1437–46.PubMedCrossRef
79.
Zurück zum Zitat Lin FJ, Samp J, Munoz A, Wong PS, Pickard AS. Evaluating change using patient-reported outcome measures in knee replacement: the complementary nature of the EQ-5D index and VAS scores. Eur J Health Econ. 2014;15(5):489–96.PubMedCrossRef Lin FJ, Samp J, Munoz A, Wong PS, Pickard AS. Evaluating change using patient-reported outcome measures in knee replacement: the complementary nature of the EQ-5D index and VAS scores. Eur J Health Econ. 2014;15(5):489–96.PubMedCrossRef
80.
Zurück zum Zitat Brazier JE, Harper R, Munro J, Walters SJ, Snaith ML. Generic and condition-specific outcome measures for people with osteoarthritis of the knee. Rheumatology (Oxford). 1999;38(9):870–7.CrossRef Brazier JE, Harper R, Munro J, Walters SJ, Snaith ML. Generic and condition-specific outcome measures for people with osteoarthritis of the knee. Rheumatology (Oxford). 1999;38(9):870–7.CrossRef
81.
Zurück zum Zitat Giesinger K, Hamilton DF, Jost B, Holzner B, Giesinger JM. Comparative responsiveness of outcome measures for total knee arthroplasty. Osteoarthritis Cartil. 2014;22(2):184–9.CrossRef Giesinger K, Hamilton DF, Jost B, Holzner B, Giesinger JM. Comparative responsiveness of outcome measures for total knee arthroplasty. Osteoarthritis Cartil. 2014;22(2):184–9.CrossRef
82.
Zurück zum Zitat Dawson J, Boller I, Doll H, Lavis G, Sharp R, Cooke P, Jenkinson C. Responsiveness of the Manchester-Oxford Foot Questionnaire (MOXFQ) compared with AOFAS, SF-36 and EQ-5D assessments following foot or ankle surgery. J Bone Jt Surg Br. 2012;94(2):215–21.CrossRef Dawson J, Boller I, Doll H, Lavis G, Sharp R, Cooke P, Jenkinson C. Responsiveness of the Manchester-Oxford Foot Questionnaire (MOXFQ) compared with AOFAS, SF-36 and EQ-5D assessments following foot or ankle surgery. J Bone Jt Surg Br. 2012;94(2):215–21.CrossRef
84.
Zurück zum Zitat DeVine J, Norvell DC, Ecker E, Fourney DR, Vaccaro A, Wang J, Andersson G. Evaluating the correlation and responsiveness of patient-reported pain with function and quality-of-life outcomes after spine surgery. Spine (Phila Pa 1976). 2011;36(21 Suppl):S69–74.CrossRef DeVine J, Norvell DC, Ecker E, Fourney DR, Vaccaro A, Wang J, Andersson G. Evaluating the correlation and responsiveness of patient-reported pain with function and quality-of-life outcomes after spine surgery. Spine (Phila Pa 1976). 2011;36(21 Suppl):S69–74.CrossRef
85.
Zurück zum Zitat Godil SS, Parker SL, Zuckerman SL, Mendenhall SK, Glassman SD, McGirt MJ. Accurately measuring the quality and effectiveness of lumbar surgery in registry efforts: determining the most valid and responsive instruments. Spine J. 2014;14(12):2885–91.PubMedCrossRef Godil SS, Parker SL, Zuckerman SL, Mendenhall SK, Glassman SD, McGirt MJ. Accurately measuring the quality and effectiveness of lumbar surgery in registry efforts: determining the most valid and responsive instruments. Spine J. 2014;14(12):2885–91.PubMedCrossRef
86.
Zurück zum Zitat Solberg T, Johnsen LG, Nygaard ØP, Grotle M. Can we define success criteria for lumbar disc surgery? Estimates for a substantial amount of improvement in core outcome measures. Acta Orthop. 2013;84(2):196–201.PubMedCentralPubMedCrossRef Solberg T, Johnsen LG, Nygaard ØP, Grotle M. Can we define success criteria for lumbar disc surgery? Estimates for a substantial amount of improvement in core outcome measures. Acta Orthop. 2013;84(2):196–201.PubMedCentralPubMedCrossRef
87.
Zurück zum Zitat Staerkle RF, Villiger P. Simple questionnaire for assessing core outcomes in inguinal hernia repair. Br J Surg. 2011;98(1):148–55.PubMedCrossRef Staerkle RF, Villiger P. Simple questionnaire for assessing core outcomes in inguinal hernia repair. Br J Surg. 2011;98(1):148–55.PubMedCrossRef
88.
Zurück zum Zitat Lee L, Mata J, Augustin BR, Carli F, Morin N, Latimer E, Feldman LS. A comparison of the validity of two indirect utility instruments as measures of postoperative recovery. J Surg Res. 2014;190(1):79–86.PubMedCrossRef Lee L, Mata J, Augustin BR, Carli F, Morin N, Latimer E, Feldman LS. A comparison of the validity of two indirect utility instruments as measures of postoperative recovery. J Surg Res. 2014;190(1):79–86.PubMedCrossRef
89.
Zurück zum Zitat Tosh J, Brazier J, Evans P, Longworth L. A review of generic preference-based measures of health-related quality of life in visual disorders. Value Health. 2012;15(1):118–27.PubMedCentralPubMedCrossRef Tosh J, Brazier J, Evans P, Longworth L. A review of generic preference-based measures of health-related quality of life in visual disorders. Value Health. 2012;15(1):118–27.PubMedCentralPubMedCrossRef
90.
Zurück zum Zitat Ang M, Fenwick E, Wong TY, Lamoureux E, Luo N. Utility of EQ-5D to assess patients undergoing cataract surgery. Optom Vis Sci. 2013;90(8):861–6.PubMedCrossRef Ang M, Fenwick E, Wong TY, Lamoureux E, Luo N. Utility of EQ-5D to assess patients undergoing cataract surgery. Optom Vis Sci. 2013;90(8):861–6.PubMedCrossRef
91.
Zurück zum Zitat Fenwick EK, Xie J, Ratcliffe J, Pesudovs K, Finger RP, Wong TY, Lamoureux EL. The impact of diabetic retinopathy and diabetic macular edema on health-related quality of life in type 1 and type 2 diabetes. Invest Ophthalmol Vis Sci. 2012;53(2):677–84. doi:10.1167/iovs.11-8992.PubMedCrossRef Fenwick EK, Xie J, Ratcliffe J, Pesudovs K, Finger RP, Wong TY, Lamoureux EL. The impact of diabetic retinopathy and diabetic macular edema on health-related quality of life in type 1 and type 2 diabetes. Invest Ophthalmol Vis Sci. 2012;53(2):677–84. doi:10.​1167/​iovs.​11-8992.PubMedCrossRef
92.
Zurück zum Zitat Maes IH, Joore MA, Cima RF, Vlaeyen JW, Anteunis LJ. Assessment of health state in patients with tinnitus: a comparison of the EQ-5D and HUI mark III. Ear Hear. 2011;32(4):428–35.PubMedCrossRef Maes IH, Joore MA, Cima RF, Vlaeyen JW, Anteunis LJ. Assessment of health state in patients with tinnitus: a comparison of the EQ-5D and HUI mark III. Ear Hear. 2011;32(4):428–35.PubMedCrossRef
93.
Zurück zum Zitat Wu AW, Hanson KA, Harding G, Haider S, Tawadrous M, Khachatryan A, Pashos CL, Simpson KN. Responsiveness of the MOS-HIV and EQ-5D in HIV-infected adults receiving antiretroviral therapies. Health Qual Life Outcomes. 2013;. doi:10.1186/1477-7525-11-42. Wu AW, Hanson KA, Harding G, Haider S, Tawadrous M, Khachatryan A, Pashos CL, Simpson KN. Responsiveness of the MOS-HIV and EQ-5D in HIV-infected adults receiving antiretroviral therapies. Health Qual Life Outcomes. 2013;. doi:10.​1186/​1477-7525-11-42.
94.
Zurück zum Zitat König HH, Ulshöfer A, Gregor M, von Tirpitz C, Reinshagen M, Adler G, Leidl R. Validation of the EuroQol questionnaire in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2002;14(11):1205–15.PubMedCrossRef König HH, Ulshöfer A, Gregor M, von Tirpitz C, Reinshagen M, Adler G, Leidl R. Validation of the EuroQol questionnaire in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2002;14(11):1205–15.PubMedCrossRef
95.
Zurück zum Zitat Stark RG, Reitmeir P, Leidl R, König HH. Validity, reliability, and responsiveness of the EQ-5D in inflammatory bowel disease in Germany. Inflamm Bowel Dis. 2010;16(1):42–51.PubMedCrossRef Stark RG, Reitmeir P, Leidl R, König HH. Validity, reliability, and responsiveness of the EQ-5D in inflammatory bowel disease in Germany. Inflamm Bowel Dis. 2010;16(1):42–51.PubMedCrossRef
96.
Zurück zum Zitat Bushnell DM, Martin ML, Ricci JF, Bracco A. Performance of the EQ-5D in patients with irritable bowel syndrome. Value Health. 2006;9(2):90–7.PubMedCrossRef Bushnell DM, Martin ML, Ricci JF, Bracco A. Performance of the EQ-5D in patients with irritable bowel syndrome. Value Health. 2006;9(2):90–7.PubMedCrossRef
98.
99.
Zurück zum Zitat Chapman JR, Norvell DC, Hermsmeyer JT, Bransford RJ, DeVine J, McGirt MJ, Lee MJ. Evaluating common outcomes for measuring treatment success for chronic low back pain. Spine (Phila Pa 1976). 2011;36(21 Suppl1):S54–68.CrossRef Chapman JR, Norvell DC, Hermsmeyer JT, Bransford RJ, DeVine J, McGirt MJ, Lee MJ. Evaluating common outcomes for measuring treatment success for chronic low back pain. Spine (Phila Pa 1976). 2011;36(21 Suppl1):S54–68.CrossRef
100.
Zurück zum Zitat Campbell H, Rivero-Arias O, Johnston K, Gray A, Fairbank J, Frost H, UK MRC Spine Stabilization Trial. Responsiveness of objective, disease-specific, and generic outcome measures in patients with chronic low back pain: an assessment for improving, stable, and deteriorating patients. Spine (Phila Pa 1976). 2006;31(7):815–22.CrossRef Campbell H, Rivero-Arias O, Johnston K, Gray A, Fairbank J, Frost H, UK MRC Spine Stabilization Trial. Responsiveness of objective, disease-specific, and generic outcome measures in patients with chronic low back pain: an assessment for improving, stable, and deteriorating patients. Spine (Phila Pa 1976). 2006;31(7):815–22.CrossRef
101.
Zurück zum Zitat Soer R, Reneman MF, Speijer BL, Coppes MH, Vroomen PC. Clinimetric properties of the EuroQol-5D in patients with chronic low back pain. Spine J. 2012;12(11):1035–9.PubMedCrossRef Soer R, Reneman MF, Speijer BL, Coppes MH, Vroomen PC. Clinimetric properties of the EuroQol-5D in patients with chronic low back pain. Spine J. 2012;12(11):1035–9.PubMedCrossRef
102.
Zurück zum Zitat Aggarwal R, Wilke CT, Pickard AS, Vats V, Mikolaitis R, Fogg L, Block JA, Jolly M. Psychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosus. J Rheumatol. 2009;36(6):1209–16.PubMedCrossRef Aggarwal R, Wilke CT, Pickard AS, Vats V, Mikolaitis R, Fogg L, Block JA, Jolly M. Psychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosus. J Rheumatol. 2009;36(6):1209–16.PubMedCrossRef
103.
Zurück zum Zitat Coast J, Peters TJ, Richards SH, Gunnell DJ. Use of the EuroQoL among elderly acute care patients. Qual Life Res. 1998;7(1):1–10.PubMedCrossRef Coast J, Peters TJ, Richards SH, Gunnell DJ. Use of the EuroQoL among elderly acute care patients. Qual Life Res. 1998;7(1):1–10.PubMedCrossRef
104.
Zurück zum Zitat Holland R, Smith RD, Harvey I, Swift L, Lenaghan E. Assessing quality of life in the elderly: a direct comparison of the EQ-5D and AQoL. Health Econ. 2004;13(8):793–805.PubMedCrossRef Holland R, Smith RD, Harvey I, Swift L, Lenaghan E. Assessing quality of life in the elderly: a direct comparison of the EQ-5D and AQoL. Health Econ. 2004;13(8):793–805.PubMedCrossRef
105.
Zurück zum Zitat The measurement and valuation of health status using EQ-5D: A European perspective. Dordrecht, The Netherlands: Kluwer Academic Publishers; 2003. The measurement and valuation of health status using EQ-5D: A European perspective. Dordrecht, The Netherlands: Kluwer Academic Publishers; 2003.
106.
Zurück zum Zitat Feeny D. Preference-based meausres: utility and quality-adjusted life years. In: Fayers P, Hays R, editors. Assessing quality of life in clinical trials. 2nd ed. New York: Oxford University Press; 2005. p. 405–30. Feeny D. Preference-based meausres: utility and quality-adjusted life years. In: Fayers P, Hays R, editors. Assessing quality of life in clinical trials. 2nd ed. New York: Oxford University Press; 2005. p. 405–30.
107.
Zurück zum Zitat Coons SJ, Rao S, Keininger DL, Hays RD. A comparative review of generic quality-of-life instruments. Pharmacoeconomics. 2000;17(1):13–35.PubMedCrossRef Coons SJ, Rao S, Keininger DL, Hays RD. A comparative review of generic quality-of-life instruments. Pharmacoeconomics. 2000;17(1):13–35.PubMedCrossRef
108.
Zurück zum Zitat Brazier J, Roberts J, Tsuchiya A, Busschbach J. A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ. 2004;13(9):873–84.PubMedCrossRef Brazier J, Roberts J, Tsuchiya A, Busschbach J. A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ. 2004;13(9):873–84.PubMedCrossRef
109.
Zurück zum Zitat Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care. 1989;27(3 Suppl):S217–32 Review.PubMedCrossRef Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care. 1989;27(3 Suppl):S217–32 Review.PubMedCrossRef
110.
Zurück zum Zitat Grosse SD, Chaugule SS, Hay JW. Estimates of utility weights in hemophilia: implications for cost-utility analysis of clotting factor prophylaxis. Expert Rev Pharmacoecon Outcomes Res. 2015;1–17. [Epub ahead of print]. Grosse SD, Chaugule SS, Hay JW. Estimates of utility weights in hemophilia: implications for cost-utility analysis of clotting factor prophylaxis. Expert Rev Pharmacoecon Outcomes Res. 2015;1–17. [Epub ahead of print].
111.
Zurück zum Zitat Revicki DA, Cella D, Hays RD, Sloan JA, Lenderking WR, Aaronson NK. Responsiveness and minimal important differences for patient reported outcomes. Health Qual Life Outcomes. 2006;4:70.PubMedCentralPubMedCrossRef Revicki DA, Cella D, Hays RD, Sloan JA, Lenderking WR, Aaronson NK. Responsiveness and minimal important differences for patient reported outcomes. Health Qual Life Outcomes. 2006;4:70.PubMedCentralPubMedCrossRef
112.
Zurück zum Zitat Streiner DL, Norman GR. Measuring change. In: Streiner DL, Norman GR, editors. Health measurement scales: A practical guide to their development and use. 4th ed. New York: Oxford University Press; 2008. p. 277–97.CrossRef Streiner DL, Norman GR. Measuring change. In: Streiner DL, Norman GR, editors. Health measurement scales: A practical guide to their development and use. 4th ed. New York: Oxford University Press; 2008. p. 277–97.CrossRef
113.
Zurück zum Zitat Fairclough DL. Study design and protocol development. In: Fairclough DL, editor. Design and analysis of quality of life studies in clinical trials. 2nd ed. Boca Raton: Chapman & Hall/CRC; 2010. p. 29–52. Fairclough DL. Study design and protocol development. In: Fairclough DL, editor. Design and analysis of quality of life studies in clinical trials. 2nd ed. Boca Raton: Chapman & Hall/CRC; 2010. p. 29–52.
114.
Zurück zum Zitat Gerhards SA, Huibers MJ, Theunissen KA, de Graaf LE, Widdershoven GA, Evers SM. The responsiveness of quality of life utilities to change in depression: a comparison of instruments (SF-6D, EQ-5D, and DFD). Value Health. 2011;14(5):732–9.PubMedCrossRef Gerhards SA, Huibers MJ, Theunissen KA, de Graaf LE, Widdershoven GA, Evers SM. The responsiveness of quality of life utilities to change in depression: a comparison of instruments (SF-6D, EQ-5D, and DFD). Value Health. 2011;14(5):732–9.PubMedCrossRef
115.
Zurück zum Zitat Lazarus RS. Coping theory and research: past, present, and future. Psychosom Med. 1993;55(3):234–47.PubMedCrossRef Lazarus RS. Coping theory and research: past, present, and future. Psychosom Med. 1993;55(3):234–47.PubMedCrossRef
116.
Zurück zum Zitat Lazarus RS, Folkman S. Stress, appraisal and coping. New York: Springer; 1984. Lazarus RS, Folkman S. Stress, appraisal and coping. New York: Springer; 1984.
117.
Zurück zum Zitat Roesch SC, Adams L, Hines A, Palmores A, Vyas P, Tran C, Pekin S, Vaughn AA. Coping with prostate cancer: a meta-analytic review. J Behav Med. 2005;28(3):281–93.PubMedCrossRef Roesch SC, Adams L, Hines A, Palmores A, Vyas P, Tran C, Pekin S, Vaughn AA. Coping with prostate cancer: a meta-analytic review. J Behav Med. 2005;28(3):281–93.PubMedCrossRef
118.
Zurück zum Zitat Wonghongkul T, Dechaprom N, Phumivichuvate L, Losawatkul S. Uncertainty appraisal coping and quality of life in breast cancer survivors. Cancer Nurs. 2006;29(3):250–7.PubMedCrossRef Wonghongkul T, Dechaprom N, Phumivichuvate L, Losawatkul S. Uncertainty appraisal coping and quality of life in breast cancer survivors. Cancer Nurs. 2006;29(3):250–7.PubMedCrossRef
Metadaten
Titel
Can The EQ-5D Detect Meaningful Change? A Systematic Review
verfasst von
Nalin Payakachat
Mir M. Ali
J. Mick Tilford
Publikationsdatum
01.11.2015
Verlag
Springer International Publishing
Erschienen in
PharmacoEconomics / Ausgabe 11/2015
Print ISSN: 1170-7690
Elektronische ISSN: 1179-2027
DOI
https://doi.org/10.1007/s40273-015-0295-6

Weitere Artikel der Ausgabe 11/2015

PharmacoEconomics 11/2015 Zur Ausgabe